Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
immunology
Biotech
I&I biotech Triveni raises $115M for preclinical antibodies
Triveni has roped in $115 million to advance preclinical antibody treatments designed to take on immunological and inflammatory disorders.
Gabrielle Masson
Oct 2, 2024 7:00am
UCLA scoops $120M gift for immunology and immunotherapy site
Aug 28, 2024 9:25am
GSK signs $7B biobuck respiratory, immunology pact with Flagship
Jul 29, 2024 8:33am
AbbVie turns up the M&A heat with $250M Celsius buy
Jun 27, 2024 11:00am
Melodia sings $275M song for Alivexis' cathepsin C inhibitor
Jun 21, 2024 5:07am
Sanofi to surf Belharra in $700M biobucks immunology deal
Jun 18, 2024 7:00am